Postmortem brain tissue for drug discovery in psychiatric research

Schizophrenia Bulletin

Volumn 35, Issue 6, 2009, Pages 1031-1033

  Kim, Sanghyeon ^a   Webster, Maree J ^a  

^a Stanley Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; PSYCHOTROPIC AGENT;

AUTOPSY; BRAIN TISSUE; CLINICAL RESEARCH; DRUG RESEARCH; EDITORIAL; GABAERGIC SYSTEM; GENE IDENTIFICATION; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BIPOLAR DISORDER; BRAIN; DNA MICROARRAY; DRUG DEVELOPMENT; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; MAJOR DEPRESSION; NERVE CELL; PATHOLOGY; PHARMACOGENETICS; SCHIZOPHRENIA;

ANIMALS; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG DISCOVERY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PSYCHOTROPIC DRUGS; RECEPTORS, NEUROTRANSMITTER; SCHIZOPHRENIA;

EID: 70449705517     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp106     Document Type: Editorial

References (17)

1. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and neuropathology consortium. Schizophr Res. 2000;44:151-155.
2. Sanghyeon Kim, Maree J. Webster. The Stanley Neuropathology Consortium Integrative Database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacol. In press.
3. Lewis DA, Hashimoto T, Morris HM. Cell and receptor typespecific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res. 2008;14:237-248.
4. Lewis DA, Cho RY, Carter CS, et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry. 2008;165: 1585-1593.
5. Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res. 1996;19:1-17.
6. Berk M, Copolov D, Dean O, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008; 64:361-368.
7. Lavoie S, Murray MM, Deppen P, et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology. 2008; 33:2187-2199.
8. Altar CA, Vawter MP, Ginsberg SD. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology. 2009;34:18-54.
9. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53-67.
10. Vawter MP, Barrett T, Cheadle C, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull. 2001;55:641-650.
11. Shyamsundar R, Kim YH, Higgins JP, et al. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 2005;6:R22.
12. Velculescu VE, Madden SL, Zhang L, et al. Analysis of human transcriptomes. Nat Genet. 1999;23:387-388.
13. Huffaker SJ, Chen J, Nicodemus KK, et al. A primatespecific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med. 2009;15:509-518.
14. Nica AC, Dermitzakis ET. Using gene expression to investigate the genetic basis of complex disorders. Hum Mol Genet. 2008;17:R129-134.
15. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452: 423-428.
16. Heinzen EL, Ge D, Cronin KD, et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol. 2008;6:e1.
17. Kim S, Webster MJ. Correlation analysis between genomewide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders [published online ahead of print September 02, 2008]. Mol Psychiatry. doi:10.1038/mp.2008.99.